Ali Abu-Alfa

Dr Ali Abu-Alfa is a tenured Professor of Medicine, and Chairperson of the Department of Internal Medicine at the American University of Beirut (AUB). He is the Director for the Human Research Protection Program at AUB, and for Research Affairs at AUB Medical Center. He joined AUB in 2010 after spending 2 decades at the Yale School of Medicine and remains Professor Adjunct at Yale in the Section of Nephrology. He led the Division of Nephrology and Hypertesion at AUB from 2010 to 2023.

He earned his MD degree from AUB in 1985, completed a residency in Internal Medicine at Northwestern University in 1990 and a fellowship in Nephrology at Yale in 1993. He is board-certified by the American Board of Internal Medicine-Nephrology, is a certified hypertension specialist (AHSCP) and a Fellow of the American Heart Association and member of its hypertension council.

Dr Abu-Alfa is the immediate past Chair of the International Society of Nephrology (ISN)-Middle East Regional Board. He assumed the role of Chair of ISN Renal Disaster Preparedness Working Group in April 2023. He is a former member of the ISN Dialysis and CME committees and had completed a 3-year term as member of the KDIGO Executive committee in Dec 2018. He is the immediate past-President of the Lebanese Society of Nephrology and Hypertension.

Dr Abu-Alfa has been a strong advocate for peritoneal dialysis (PD) for over 25 years. He has been involved in ISPD in leadership roles since 2008, first as co-Chair of the North American Chapter then as founding and current Chair of the Middle East Chapter, in addition to serving on its various committees over the years. Most recently, he was instrumental in helping put together the successful bid for ISPD 2024 congress to be held in Dubai, United Arab Emirates (Sept 26-29), and is co-chair for the organizing committee and the scientific program committee.

In addition to his strong engagement in these regional and international nephrology circles, Dr Abu-Alfa continues to teach and mentor students, residents and fellows while pursuing his scientific interests in the areas of peritoneal dialysis, complex hypertension, chronic kidney disease, imaging issues in kidney patients including nephrogenic systemic fibrosis and use of gadolinium-based contrast agents. He is also very active in the sphere of research ethics, its regulatory and administrative frameworks, and protection of human subjects in research.